Asian press release distribution

Press Releases for Thursday, July 23, 2020

Wintermar Offshore (WINS) Expects Conditions to Improve in 2021 as Recovery in OSV Industry is Delayed by COVID-19 Impact on Oil Price 21:00 HKT/SGT

要约人建议透过协议计划方式私有化中国宝丰国际及撤销其上市地位 18:12 HKT/SGT

要約人建議透過協議計劃方式私有化中國寶豐國際及撤銷其上市地位 18:11 HKT/SGT

Proposed Privatisation of China Baofeng (International) Limited by the Offeror by way of a Scheme of Arrangement and Withdrawal of Listing of China Baofeng (International) Limited 18:10 HKT/SGT

Inaugural 'Standard Chartered GBA Business Confidence Index' 18:00 HKT/SGT

Mazda's Future Factory Operation Plans 13:17 HKT/SGT

Greenbriar Comments on Recent Controversy on Social Media 13:00 HKT/SGT

德事商务中心进一步在中国大陆三个地区拓展全球发展足迹 10:02 HKT/SGT

德事商務中心擴展環球足跡至中國三個地區 10:01 HKT/SGT

TEC Expands Global Footprint Across Three Locations in China 10:00 HKT/SGT

国美零售携手央视新闻加速推进本地化零售布局 09:04 HKT/SGT

國美零售攜手央視新聞加速推進本地化零售佈局 09:03 HKT/SGT

银城国际获安信国际首次研报覆盖，评级「买入」并给予目标价2.8港元 09:01 HKT/SGT

銀城國際獲安信國際首次研報覆蓋，評級「買入」並給予目標價2.8港元 09:00 HKT/SGT

中国抗体与D2M建立战略合作关系 07:22 HKT/SGT

中國抗體與D2M建立戰略合作關係 07:21 HKT/SGT

SinoMab entered into Strategic Collaboration with D2M 07:20 HKT/SGT

아방스 클리니컬, 아토사 테라퓨틱스의 두 번째 코로나19 치료제 개발 프로그램인 비강 분무용 치료제 AT-301 임상 연구 계약 06:00 HKT/SGT

Avance Clinical簽約展開Atossa Therapeutics AT-301鼻噴霧劑臨床研究，這是Atossa的第二個新冠肺炎治療開發項目 06:00 HKT/SGT

Avance Clinical签约展开Atossa Therapeutics AT-301鼻喷雾剂临床研究，这是Atossa的第二个新冠肺炎治疗开发项目 06:00 HKT/SGT

ACN Search:

CleverTap launches Clever.AI, the AI-Driven Edge for Customer Engagement & Retention


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Cookies Policy \| Privacy Policy \| Disclaimer \| Terms of Use \| RSS

US: +1 214 890 4418 \| China: +86 181 2376 3721 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575